Back to All Events

EFS is the New OUS Strategy for Early-Phased Medical Device Clinical Trials

This session will provide the participant with several real-world examples of the benefits and risks of conducting early-phased medical device clinical trials, and the strategies involved in optimizing this avenue for regulatory submissions. The participant will obtain tools to develop successful clinical and regulatory strategies for new devices and indications.


  • Christopher Cain, CCRA, RAC, VP, Clinical and Regulatory Affairs, Corindus Vascular Robotics, Inc.